Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose.

Community genetics - 1 Jan 2007

Tanira Musbah O, Al-Mukhaini Mohammed K, Al-Hinai Ali T, Al Balushi Khalid A, Ahmed Ikhlas S

Abstract excerpt

OBJECTIVES: This study was conducted to determine the frequency of CYP2C9 alleles in Omani patients receiving warfarin and to correlate genotyping data with warfarin dosage. The Omani population has Asian and African ethnicities. METHODS: CYP2C9 genotypes were determined by the polymerase chain reaction restriction fragment length polymorphism method. Non-parametric Kruskal-Wallis test was used to compare groups...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Gene Frequency

Share to Pharmacogenetics

Share to Polymorphism, Restriction Fragment Length

Share to Warfarin

Source

Identifiers

PMID: 17167248
DOI: 10.1159/000096279

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Frequency of CYP2C9 genotypes among Omani patients receiving warfarin and its correlation with warfarin dose.PMID 17167248Read ↗

Warfarin pharmacogenetics: polymorphisms of the CYP2C9, CYP4F2, and VKORC1 loci in a genetically admixed Omani population.Semantic proximity Read ↗

Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR.Semantic proximity Read ↗

Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients.Semantic proximity Read ↗

VKORC1 and CYP2C9 genotype distribution in Asian countries.Semantic proximity Read ↗

Variability in CYP2C9 allele frequency: a pilot study of its predicted impact on warfarin response among healthy South and North Indians.Semantic proximity Read ↗

Allele and genotype frequencies of CYP2C9 within an Iranian population (Mazandaran).Semantic proximity Read ↗

Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy.Semantic proximity Read ↗

Factors affecting warfarin dose requirements and quality of anticoagulation in adult Egyptian patients: role of gene polymorphism.Semantic proximity Read ↗

CYP2C9 polymorphism: prevalence in healthy and warfarin-treated Malay and Chinese in Malaysia.Semantic proximity Read ↗

Impact of CYP2C9 genetic polymorphism on warfarin dose requirements in Pakistani population.Semantic proximity Read ↗

Frequency of VKORC1 (C1173T) and CYP2C9 genetic polymorphisms in Egyptians and their influence on warfarin maintenance dose: proposal for a new dosing regimen.Semantic proximity Read ↗

Malaysian Indians are genetically similar to Caucasians: CYP2C9 polymorphism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.